CNPR Clinical Trials 2

Question 1

Which regulatory document must be reviewed and signed by each participant before enrolling in a clinical trial?

Accepted Answer

Informed consent form

Answer

The informed consent form must be reviewed, understood, and signed by each participant before enrollment to protect patient autonomy.

Question 2

What is the primary purpose of a placebo control group in a clinical trial?

Accepted Answer

To provide a baseline for comparing the investigational drug's effects

Answer

A placebo control group provides a baseline comparator so researchers can isolate the true pharmacological effect of the investigational drug.

Question 3

What does the term 'double-blind' mean in the context of a clinical trial?

Accepted Answer

Neither the participant nor the investigator knows who receives active drug or placebo

Answer

Double-blind means both the participant and the investigator are unaware of treatment assignments, reducing bias in assessment and reporting.

Question 4

In clinical trial terminology, what is an 'endpoint'?

Accepted Answer

A measurable outcome used to evaluate the drug's effect

Answer

An endpoint is a predefined, measurable outcome such as tumor reduction or blood pressure change used to evaluate whether the drug achieves its intended effect.

Question 5

Which type of clinical trial design randomly assigns participants to treatment groups?

Accepted Answer

Randomized controlled trial

Answer

A randomized controlled trial (RCT) uses random assignment to treatment groups, minimizing selection bias and allowing causal conclusions.

(CNPR) Certified National Pharmaceutical Representative Practice Test

(CNPR) Certified National Pharmaceutical Representative Practice Test

CNPR Clinical Trials 2